Previous Article | Next Article ![]()
Journal of Clinical Microbiology, January 2001, p. 389-391, Vol. 39, No. 1
Department of Clinical Microbiology & Infectious Diseases, Hadassah-University
Hospital,1 and Department of
Pediatrics, Bikur Holim General Hospital,2
Jerusalem, Israel
Received 10 July 2000/Returned for modification 17 September
2000/Accepted 27 October 2000
In a retrospective 10-year analysis of 3,536 patient-unique
isolates, Acinetobacter baumannii imipenem susceptibility
declined from 98.1 (1990) to 64.1% (2000), and ciprofloxacin
susceptibility decreased from 50.5 to 13.1%. Imipenem median zone
diameters decreased from 27.7 (1997) to 18.8 mm (2000). No outbreaks
were detected. Two clusters were identified for 41 strains genotyped by
pulsed-field gel electrophoresis, but imipenem resistance was
not clonal.
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.1.389-391.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Acinetobacter baumannii at a
Tertiary-Care Teaching Hospital in Jerusalem, Israel
*
Corresponding author. Mailing address: Dept. of
Clinical Microbiology & Infectious Diseases, P.O. Box 12000, Jerusalem
91120, Israel. Phone: 972-2-677-6543. Fax: 972-2-641-9545. E-mail:
simhon{at}hadassah.org.il.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»